Assessing the estrogenic and dioxin-like activities of chemicals and complex mixtures using in vitro recombinant receptor-reporter gene assays

Canadian Journal of Physiology and Pharmacology

Volumn 74, Issue 2, 1996, Pages 216-222

  Balaguer, Patrick ^a   Joyeux, Annick ^a   Denison, Michael S ^b   Vincent, Renaud ^c   Gillesby, Bradley E ^d   Zacharewski, Tim ^d  

^a INSERM   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

bioassays; dioxin like; environmental estrogen; in vitro; receptor

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ATRAZINE; ESTRADIOL; ESTROGEN RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NARINGENIN; SIMAZINE;

ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; GUINEA PIG; HUMAN; HUMAN CELL; INFERTILITY; PRIORITY JOURNAL; REPORTER GENE;

AIR POLLUTANTS; ATRAZINE; BIOLOGICAL ASSAY; FLAVANONES; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC TECHNIQUES; HELA CELLS; HERBICIDES; HUMANS; LUCIFERASES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; SIMAZINE;

EID: 0029929216     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-74-2-216     Document Type: Conference Paper

References (69)

1. Aldercreutz, H. 1990. Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 50(Suppl. 201):3-23.
2. Anazano, M.A., Smith, J.M., Uskokovic, M.R., Peer, C.W., Mullen, L.T., Letterio, J.J., Welsh, M.C., Brown, C.C., Roberts, A.B., and Sporn, M.B. 1994. 1α,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro 24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res. 54: 1653-1656.
3. Berry, M., Metzger, D., and Chambon, P. 1990. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonist activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J. 9: 2811-2818.
4. 125I]-2-iodo-7,8-dibromodibenzo-p-dioxin. Mol. Pharmacol. 34:229-237.
5. Brasier, A.R., Tate, J.E., and Habener, J.F. 1989. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques, 7: 1116-1122.
6. Bulger, W.H., and Kupfer, D. 1983. Estrogenic action of DDT analogs. Am. J. Ind. Med. 4: 163-173.
7. Bunce, N., Logan, R., and Schneider, U. 1990. Development of a rapid screening assay for PCDDs and PCDFs. Chemosphere, 20: 1417-1422.
8. Clark, J.H., Watson, C., Upchurch, S., McCormack, S., Padykula, H., Markaverich, B., and Hardin, J.W. 1980. Estrogen action in normal and abnormal cell growth. In Estrogens in the environment. Edited by J.A. McLachlan. Elsevier, New York. pp. 53-67.
9. Colburn, T., and Clement, C. 1992. Chemically-induced alterations in sexual and functional development: the wildlife/human connection. Princeton Scientific Publishing Co., Princeton.
10. Colborn, T., vom Saal, F.S., and Soto, A.M. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspec. 101: 378-384.
11. Connor, K., Howell, J., Chen, I., Liu, H., Berhane, K., Sciarretta, C., Safe, S., and Zacharewski, T. 1996. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam. Appl. Toxicol. 30: 93-101.
12. Cullen, K.J., Lippman, M.E., Chow, D., Hill, S., Rosen, N., and Zwiebel, J.A. 1992. Insulin-like growth factor-II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol. 6: 91-100.
13. Daly, R.J., King, R.J.B., and Dabre, P.A. 1990. Interaction of growth factors during progression towards steroid independence in T47D human breast cancer cells. J. Cell. Biochem. 43: 199-211.
14. Demirpence, E., Balaguer, P., Trousse, F., Nicolas, J.C., Pons, M., and Gagne, D. 1994. Antiestrogenic affects of retinoic acid and 1,25 dihydroxyvitamin D3 in human breast cancer cells occur at the estrogen response element but through different molecular mechanisms. Cancer Res. 54: 1458-1464.
15. Denison, M.S., Fischer, J.M., and Whitlock, J.P. 1988. Inducible receptor-dependent protein-DNA interactions at a dioxin responsive transcriptional enhancer. Proc. Natl. Acad. Sci. U.S.A. 85: 2528-2532.
16. El-Fouly, M.H., Richter, C., Giesy, J.P., and Denison, M.S. 1994. Production of a novel recombinant cell line for use as a bioassay system for detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like compounds. Environ. Toxicol. Chem. 13: 1581-1588.
17. Falck, F., Ricci, A., Wolff, M.S., Godbold, J., and Deckers, P. 1992. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch. Environ. Health, 47: 143-146.
18. Fitzpatrick, D.W., Picken, C.A., Murphy, L.C., and Buhr, M.M. 1989. Measurement of the relative binding affinity of zearalenol, α-zearalenol and β-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp. Biochem. Physiol. 94C: 691-694.
19. Fontana, J.A., Miranda, D., and Mezu, A.B. 1990. Retinoic acid inhibition of human breast cancer carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein. Cancer Res. 50: 1977-1982.
20. Gagne, D., Balaguer, P., Demirpence, E., Trousse, F., Nicolas, J.C., and Pons, M. 1994. Stable transfectant cells to study steroid receptor biological activity. J. Biolumin. Chemilumin. 9: 201-209.
21. Gierthy, J.F., and Crane, D. 1985. In vitro bioassay for dioxinlike activity based on alterations in epithelial proliferation and morphology. Fundam. Appl. Toxicol. 5: 754-759.
22. Gierthy, J.F., Lincoln, D.W., Roth, K.E., Bowser, S.S., Bennett, J.A., Bradley, L., and Dickerman, H.W. 1991. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells. J. Cell. Biochem. 45: 177-187.
23. Henderson, B.E., Ross, R., and Bernstein, L. 1988. Estrogens as a cause of human cancer. Cancer Res. 48: 246-253.
24. Herman, M.E., and Katzenellenbogen, B.S. 1994. Alterations in transforming growth factor alpha and beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res. 54: 5867-5874.
25. Hileman, B. 1994. Environmental estrogens linked to reproductive abnormalities, cancer. Chem. Eng. News, 31: 19-23.
26. Huff, K.K., Kaufman, D., Gabbay, K.H., Spencer, M., Lippman, M.E., and Dickson, R.B. 1986. Secretion of insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res. 46:4613-4619.
27. Jausons-Loffreda, N., Balaguer, P., Auzou, G., and Pons, M. 1994a. Development of specific bioluminescent in vitro assays for selecting potential antimineralocorticoids. J. Steroid Biochem. Mol. Biol. 49: 31-38.
28. Jausons-Loffreda, N., Gelmini, N., Pazzagli, N., Joyeux, A., Balaguer, P., Pons, M., and Nicolas, J.C. 1994b. Chimeric receptor genes as a tool for measuring biological activities of steroid hormones. J. Biolumin. Chemilumin. 49: 31-38.
29. Jobling, S., Reynolds, T., White, R., Parker, M.G., and Sumpter, J.P. 1995. A variety of environmentally persistent chemicals, including some plasticizers, are weakly estrogenic. Environ. Health Perspect. 103: 582-587.
30. Jordan, V.C., Koch, R., and Bain, R.R. 1985. Prolactin synthesis by cultured rat pituitary cells: an assay to study estrogens, antiestrogens and their metabolites in vitro. In Estrogens in the environment. II. Edited by J.A. McLachlan. Elsevier, New York.
31. Keller, H., Givel, F., Perroud, M., and Wahli, W. 1995. Signaling cross-talk between peroxisome proliferator activated receptor/retinoid X receptor through estrogen response elements. Mol. Endocrinol. 9: 794-804.
32. Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L., and Feldman, D. 1993. Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology (Baltimore), 132: 2279-2286.
33. Lewis, M.A. 1991. Chronic and sublethal toxicities of surfactants to aquatic animals: a review and risk assessment. Water Res. 25: 101-113.
34. Littlefield, B.A., Gurpide, E., Markiewicz, L., McKinley, B., and Hochberg, R.B. 1990. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phoshatase in Ishikawa cells: estrogen action of adrenal steroids. Endocrinology (Baltimore), 127: 2757-2762.
35. Lusska, A., Shen, E.S., and Whitlock, J.P. 1993. Protein-DNA interactions at a dioxin-responsive enhancer. Analysis of six bona fide DNA-binding sites for the liganded Ah receptor. J. Biol. Chem. 268: 6575-6580.
36. Martin, P.M., Horwitz, K.B., Ryan, D.S., and McGuire, W.L. 1978. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology (Baltimore), 103: 1860-1867.
37. Mayr, U., Butsch, A., and Schneider, S. 1992. Validation of two in vitro test systems for estrogenic activities with zeralenone, phytoestrogens and cereal extracts. Toxicology, 74: 135-149.
38. Miksicek, R.J. 1993. Commonly occurring plant flavonoids have estrogenic activity. Mol. Pharmacol. 44: 37-43.
39. Miksicek, R.J. 1994. Interaction of naturally occurring estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49: 152-160.
40. Osborne, C.K., Clemmons, D.R., and Arteaga, C.L. 1990. Regulation of breast cancer growth by insulin-like growth factors. J. Steroid Biochem. Mol. Biol. 37: 805-809.
41. Pons, M., Gagne, D., Nicolas, J.C., and Methali, M. 1990. A new cellular model of response to estrogens: a bioluminescent test to characterize (anti)estrogen molecules. Biotechniques, 9: 450-459.
42. Robison, A.K., Schmidt, W.A., and Stancel, G.M. 1985. Estrogenic activity of DDT: estrogen receptor profiles and the responses of individual uterine cell types following o,p-DDT administration. J. Toxicol. Environ. Health, 16: 493-508.
43. Rubin, M., Fenig, E., Rosenauer, A., Menendez-Botet, C., Achkar, C., Bentel, J.M., Yahalom, J., Mendelsohn, J., and Miller, W.H. 1994. 9-cis retinoic acid inhibits growth of human breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res. 54: 6549-6556.
44. Ruh, M.F., Zacharewski, T., Connor, K., Howell, J., Chen, I., and Safe, S. 1995. Naringenin: a weak estrogenic bioflavonoid that exhibits antiestrogenic activity. Biochem. Pharmacol. 50(9): 1485-1493.
45. Safe, S.H. 1995a. Assessing the role of environmental estrogens in human reproductive health. Health Environ. Digest, 8: 79-81.
46. Safe, S.H. 1995b. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds. Pharmacol. Ther. 67: 247-281.
47. Safe, S., Astroff, B., Harris, M., Zacharewski, T., Dickerson, R., Romkes, M., and Biegel, L. 1991a. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related compounds as antiestrogens: characterization and mechanism of action. Pharmacol. Toxicol. 69: 400-409.
48. Safe, S., Harris, M., Biegel, L., and Zacharewski, T. 1991b. Mechanism of action of TCDD as an antiestrogen in transformed human breast cancer and rodent cell lines. Banbury Report, 35: 367-377.
49. Sambrook, J., Fristch, E.F., and Maniatis, T. 1989. Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, New York.
50. Santen, R.J., Manni, A., Harvey, H., and Redmond, C. 1990. Endocrine treatment of breast cancer in women. Endocr. Rev. 11: 221-265.
51. Segars, J.H., Marks, M.S., Hirschfeld, S., Driggers, P.H., Martinez, E., Grippo, J.F., Wahli, W., and Ozato, K. 1993. Inhibition of estrogen-responsive gene activation by the retinoid CHI receptor β: evidence for multiple inhibitory pathways. Mol. Cell. Biol. 13: 2258-2269.
52. Sharpe, R.M., and Skakkebaek, N.E. 1993. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet, 341: 1392-1395.
53. Soto, A.M., Lin, T.-M., Justicia, H., Silvia, R.M., and Sonnenschein, C. 1992. An "in culture" bioassay to assess the estrogenicity of xenobiotics (E-Screen). Adv. Modern Environ. Toxicol. 21: 295-309.
54. Tillit, D.E., Giesy, J.P., and Ankley, G.T. 1991. Characterization of the H4IIE rat hepatoma cell bioassay us a tool for assessing toxic potency of planar halogenated hydrocarbons in environmental samples. Environ. Sci. Technol. 25: 87-92.
55. Tora, L., White, J., Brou, C., Tasset, D., Webster, N., Scheer, E., and Chambon, P. 1989. The human estrogen receptor has two independent nonacidic transcriptional activation functions. Cell. 59: 477-487.
56. Van Der Burg, B., Rutteman, G.R., Bloukenstein, M.A., De Laat, S.W., and Van Zoelen, E.J.J. 1988. Mitogenic stimulation of human breast cancer cells in a growth defined medium: synergistic action of insulin and estrogen. J. Cell Physiol. 134: 101-108.
57. Van Der Burg, B., De Groot, R., Isbrucker, L., Kruijer, W., and De Laat, S.W. 1991. Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 40: 215-221.
58. Van Der Burg, B., De Groot, R.P., Isbrucker, L., Kruijer, W., and De Laat, S.W. 1992. Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells. J. Steroid Biochem. Mol. Biol. 43: 111-115.
59. Van Der Kraak, G.L., Munkittrick, K.R., McMaster, M.E., Portt, C.B., and Chang, J.P. 1992. Exposure to bleached kraft pulp mill effluent disrupts the pituitary-gonadal axis of white sucker at multiple sites. Toxicol. Appl. Pharmacol. 115: 224-233.
60. Verdeal, K., and Ryan, D. 1979. Naturally-occurring estrogens in plant foodstuffs: a review. J. Food Prot. 42: 577-583.
61. Vessey, M.P. 1989. The involvement of estrogen in the development and progression of breast disease: epidemiological evidence. Proc. R. Soc. Edinb. Sect. B, Biol. Sci. 95: 35-48.
62. Webster, N.J.G., Green, S., Tasset, D., Ponglikitmongkol, M., and Chambon, P. 1989. The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exon. EMBO J. 8: 1441-1446.
63. Wetzel, L.T., Luempert, L.G., Breckenridge, C.B., Tisdel, M.O., Stevens, J.T., Thakur, A.J., Extrom, P.C., and Elderidge, J.C. 1994. Chronic effects of atrazine on estrus and mammary formation in female Sprague-Dawley and Fischer 344 rats. J. Toxicol. Environ. Health, 43: 169-182.
64. White, R., Jobling, S., Hoare, S.A., Sumpter, J.P., and Parker, M.G. 1994. Environmentally persistant alkylphenolic compounds are estrogenic. Endocrinology (Baltimore), 135: 175-182.
65. Wolff, M.S., Toniolo, P.G., Lee, E.W., Rivera, M., and Dubin, N. 1993. Blood levels of organochlorine residues and risk of breast cancer. J. Natl. Cancer Inst. 85: 648-652.
66. Zacharewski, T., Harris, M., Safe, S., Thoma, H., and Hutzinger, O. 1988. Applications ot the in vitro aryl hydrocarbon hydroxylase induction assay for determining "2,3,7,8-tetrachlorodibenzo-p-dioxin equivalents": pyrolyzed brominated flame retardants. Toxicology, 51: 177-189.
67. Zacharewski, T., Safe, L., Safe, S., Chittim, B., Devault, D., Wiberg, K., Bergqvist, P.A., and Rappe, C. 1989. Comparative analysis of polychlorinated dibenzo-p-dioxin and dibenzofuran congeners in Great Lakes fish extracts by gas chromatography - mass spectrometry and in vitro enzyme induction activities. Environ. Sci. Technol. 23: 730-735.
68. Zacharewski, T., Bondy, K., McDonell, P., and Wu, Z.F. 1994. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res. 54: 2707-2713.
69. Zacharewski, T., Berhane, K., Gillesby, B., and Burnison, K. 1995. Detection of estrogen- and dioxin-like activity in pulp and paper mill black liquor effluent using in vitro recombinant receptor/reporter gene assays. Environ. Sci. Technol. 29: 2140-2146.